TRDA
Entrada Therapeutics, Inc. · Healthcare
COO Nathan J Dowden sold $246K of Entrada Therapeutics, Inc.
Sold$246,403
$15.42Price
15,982Shares
−27%Stake
What TRDA did after the filing
- The stock from Fri, Jun 23 open, $15.52
- −10.2%
- S&P 500, same days
- +4.1%
Measured over 30 trading days, to the Aug 7 close.
Traded Tue, Jun 20. Filed Thu, Jun 22, 4:46 PM ET, after the close. Returns use the Jun 23 open and the Aug 7 close. Not investment advice.